117 related articles for article (PubMed ID: 8668645)
1. Effects of captopril on ischaemia-reperfusion-induced arrhythmias in an in vivo rat model.
Olmez E; Birincioglu M; Aksoy T; Acet A
Pharmacol Res; 1995; 32(1-2):37-41. PubMed ID: 8668645
[TBL] [Abstract][Full Text] [Related]
2. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
Ozer MK; Sahna E; Birincioglu M; Acet A
Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
[TBL] [Abstract][Full Text] [Related]
3. The role of prostaglandin synthesis stimulation in the protective effect of captopril on ischaemia-reperfusion arrhythmias in rats in vivo.
Birincioglu M; Olmez E; Aksoy T; Acet A
Pharmacol Res; 1997 Oct; 36(4):299-304. PubMed ID: 9425619
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of ACE inhibitors on ischemia-reperfusion-induced arrhythmias in rats: is this effect related to the free radical scavenging action of these drugs?
Birincioglu M; Aksoy T; Olmez E; Acet A
Free Radic Res; 1997 Oct; 27(4):389-96. PubMed ID: 9416467
[TBL] [Abstract][Full Text] [Related]
5. The protective effects of CP-060S on ischaemia- and reperfusion- induced arrhythmias in anaesthetized rats.
Koga T; Fukazawa M; Suzuki Y; Akima M; Adachi Y; Tamura K; Kato T; Kuromaru O
Br J Pharmacol; 1998 Apr; 123(7):1409-17. PubMed ID: 9579737
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists.
D'Amico M; Di Filippo C; Rossi F; Rossi F
Eur J Pharmacol; 1999 Feb; 366(2-3):167-74. PubMed ID: 10082197
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
Zhu B; Sun Y; Sievers RE; Browne AE; Pulukurthy S; Sudhir K; Lee RJ; Chou TM; Chatterjee K; Parmley WW
J Am Coll Cardiol; 2000 Mar; 35(3):787-95. PubMed ID: 10716484
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of captopril against ischemia/reperfusion-induced ventricular arrhythmias in vitro and in vivo.
deGraeff PA; deLangen CD; van Gilst WH; Bel K; Scholtens E; Kingma JH; Wesseling H
Am J Med; 1988 Mar; 84(3A):67-74. PubMed ID: 3064601
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of angiotensin converting enzyme inhibitors (CEI): captopril and perindopril on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion in rat.
Rochette L; Ribuot C; Belichard P; Bril A; Devissaguet M
Clin Exp Hypertens A; 1987; 9(2-3):365-8. PubMed ID: 3038396
[TBL] [Abstract][Full Text] [Related]
10. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
Sun W; Wainwright CL
Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
[TBL] [Abstract][Full Text] [Related]
11. Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart.
Bril A; Laville MP; Gout B
Cardiovasc Res; 1992 Nov; 26(11):1069-76. PubMed ID: 1291084
[TBL] [Abstract][Full Text] [Related]
12. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Angiotensin-II Production Increases Susceptibility to Acute Ischemia/Reperfusion Arrhythmia.
Taskin E; Tuncer KA; Guven C; Kaya ST; Dursun N
Med Sci Monit; 2016 Nov; 22():4587-4595. PubMed ID: 27889788
[TBL] [Abstract][Full Text] [Related]
14. Chronic pantoprazole administration and ischemia--reperfusion arrhythmias in vivo in rats--antiarrhythmic or arrhythmogenic?
Abdel-Kawy HS
Cardiovasc Ther; 2015 Apr; 33(2):27-34. PubMed ID: 25677801
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of acidic fibroblast growth factor against cardiac arrhythmias induced by ischemia and reperfusion in rats.
Cuevas P; Carceller F; Hernández-Madrid A; Cuevas B; Martínez-Coso V; Giménez-Gallego G
Eur J Med Res; 1997 Jan; 2(1):33-6. PubMed ID: 9049592
[TBL] [Abstract][Full Text] [Related]
16. Effect of ramiprilat or captopril on myocardial infarct size: assessment in canine models of ischemia alone and ischemia with reperfusion.
Black SC; Driscoll EM; Lucchesi BR
Pharmacology; 1998 Jul; 57(1):35-46. PubMed ID: 9670211
[TBL] [Abstract][Full Text] [Related]
17. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
Westlin W; Mullane K
Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
[TBL] [Abstract][Full Text] [Related]
18. Protection by ITF 1300, a heparin ion-pair complex, against arrhythmias induced by regional ischemia and reperfusion in the isolated rat heart: possible mechanism of action.
Curtis MJ; Barsby RW; Forster R
J Cardiovasc Pharmacol; 1995 Apr; 25(4):643-51. PubMed ID: 7596134
[TBL] [Abstract][Full Text] [Related]
19. R56865, a potent new antiarrhythmic agent, effective during ischemia and reperfusion in the rat heart.
Garner JA; Hearse DJ; Bernier M
J Cardiovasc Pharmacol; 1990 Sep; 16(3):468-79. PubMed ID: 1700220
[TBL] [Abstract][Full Text] [Related]
20. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
